Imaging Firm Relocates Headquarters to Aurora Biotech Hub

Research-based manufacturers are moving closer to university medical campuses to sharpen R&D feedback cycles.

Updated on Oct. 21, 2026 in Openings & Closings

Imaging Firm Relocates Headquarters to Aurora Biotech Hub

Live Poll

Do you believe relocating businesses near research universities helps drive local innovation and growth?

Intelligent Imaging Innovations has relocated its corporate headquarters to the Fitzsimons Innovation Community in Aurora. The manufacturer of microscopy systems for research is establishing a new facility to serve its global operations.

Why it matters

The move positions the company directly adjacent to the University of Colorado Anschutz Medical Campus, facilitating closer collaboration with its core research customer base. This shift centralizes critical functions in one hub to streamline development.

The new 10,000-square-foot facility is sized to support 25 initial employees, with plans to grow staffing to 30 to 35 workers over time. The firm, which has collaborated with 8 Nobel laureates, operates across the United States, Europe, and Asia.

The players

Intelligent Imaging Innovations

A microscopy systems manufacturer founded in 1995 that serves research institutions across the United States, Europe, and Asia.

Fitzsimons Innovation Community

A life sciences business incubator and campus located in Aurora, Colorado, that hosts biotech and medical research companies.

The details

The facility at Bioscience 3 integrates manufacturing, research, development, sales, and service operations into a single location. It features a wet lab designed for hands-on research and a demonstration lab for client training. By co-locating these functions near the University of Colorado Anschutz Medical Campus, the company aims to improve feedback loops between research staff and medical professionals.

Timeline

  1. 1995: Intelligent Imaging Innovations was founded in Colorado.

  2. End of 2026: Construction of the new facility is expected to be completed.

Market Landscape

The move mirrors the established trend of biotech R&D firms clustering near major research universities to accelerate product development cycles. It follows a pattern of life sciences companies seeking proximity to academic medical centers to enhance R&D feedback.

Operators in the life sciences sector should evaluate whether their physical proximity to primary academic customers provides a tangible competitive advantage in product demonstration. The co-location of manufacturing and R&D functions may offer an opportunity to reduce internal logistical costs.

The takeaway

Centralizing research and manufacturing near a primary research institution can sharpen a product's fit for professional users. Monitor the facility's progress toward its 2026 completion to observe how this integrated model influences their operational efficiency.

What happens next

Construction of the facility is scheduled for completion by the end of 2026.

Further reading

For more on shifts in the local business landscape, visit Openings & Closings.

Source note: This article includes information reported by ColoradoBiz.

Live Poll

Do you believe relocating businesses near research universities helps drive local innovation and growth?